Global Artificial Implants Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 269
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Artificial Implants Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Artificial Implants Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
The research report includes specific segments by region (country), by Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Artificial Implants Market: By Types
Orthopedic Implants
Dental Implants
Cardiac Implants
Cochlear Implants
Global Artificial Implants Market: By Applications
Hospitals
Clinical Research Institutions
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Artificial Implants Market: Top Key Players
Abiomed (USA)
Advanced Bionics Corporation (USA)
Bicon(USA)
Biomet 3i (USA)
Biotronik(Germany)
Boston Scientific Corporation (USA)
Cochlear Limited (Australia)
Dentsply Sirona (USA)
DePuy Synthes Companies (USA)
Exactech (USA)
GS Medical(USA)
Institut Straumann AG (Switzerland)
Integra Lifesciences Holdings Corporation (USA)
Japan Medical Dynamic Marketing (Japan)
MED-EL Medical Electronics (Austria)
Medtronic plc (Ireland)
Nobel Biocare Services AG (Sweden)
RTI Surgical (USA)
Showa Ika Kohgyo (Japan)
Smith & Nephew Plc (UK)
Sonova Holding AG (Switzerland)
Abbott
Stryker Corporation (USA)
Terumo Corporation (Japan)
TTK Healthcare(India)
Wright Medical Group(Netherlands)
Zimmer Biomet Holdings (USA)
Global Artificial Implants Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Artificial Implants Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Artificial Implants Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
The research report includes specific segments by region (country), by Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Artificial Implants Market: By Types
Orthopedic Implants
Dental Implants
Cardiac Implants
Cochlear Implants
Global Artificial Implants Market: By Applications
Hospitals
Clinical Research Institutions
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Artificial Implants Market: Top Key Players
Abiomed (USA)
Advanced Bionics Corporation (USA)
Bicon(USA)
Biomet 3i (USA)
Biotronik(Germany)
Boston Scientific Corporation (USA)
Cochlear Limited (Australia)
Dentsply Sirona (USA)
DePuy Synthes Companies (USA)
Exactech (USA)
GS Medical(USA)
Institut Straumann AG (Switzerland)
Integra Lifesciences Holdings Corporation (USA)
Japan Medical Dynamic Marketing (Japan)
MED-EL Medical Electronics (Austria)
Medtronic plc (Ireland)
Nobel Biocare Services AG (Sweden)
RTI Surgical (USA)
Showa Ika Kohgyo (Japan)
Smith & Nephew Plc (UK)
Sonova Holding AG (Switzerland)
Abbott
Stryker Corporation (USA)
Terumo Corporation (Japan)
TTK Healthcare(India)
Wright Medical Group(Netherlands)
Zimmer Biomet Holdings (USA)
Global Artificial Implants Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Artificial Implants Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Artificial Implants Market Overview
1.1 Product Overview and Scope of Artificial Implants
1.2 Artificial Implants Segment by Type
1.2.1 Global Artificial Implants Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Orthopedic Implants
1.2.3 Dental Implants
1.2.4 Cardiac Implants
1.2.5 Cochlear Implants
1.3 Artificial Implants Segment by Application
1.3.1 Artificial Implants Sales Comparison by Application: (2022-2030)
1.3.2 Hospitals
1.3.3 Clinical Research Institutions
1.3.4 Others
1.4 Global Artificial Implants Market Size Estimates and Forecasts
1.4.1 Global Artificial Implants Revenue 2016-2030
1.4.2 Global Artificial Implants Sales 2016-2030
1.4.3 Artificial Implants Market Size by Region: 2016 Versus 2022 Versus 2030
2 Artificial Implants Market Competition by Manufacturers
2.1 Global Artificial Implants Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Implants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Implants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Implants Manufacturing Sites, Area Served, Product Type
2.5 Artificial Implants Market Competitive Situation and Trends
2.5.1 Artificial Implants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Implants Players Market Share by Revenue
2.5.3 Global Artificial Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Implants Retrospective Market Scenario by Region
3.1 Global Artificial Implants Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Artificial Implants Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Artificial Implants Market Facts & Figures by Country
3.3.1 North America Artificial Implants Sales by Country
3.3.2 North America Artificial Implants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Implants Market Facts & Figures by Country
3.4.1 Europe Artificial Implants Sales by Country
3.4.2 Europe Artificial Implants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Implants Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Implants Sales by Region
3.5.2 Asia Pacific Artificial Implants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Implants Market Facts & Figures by Country
3.6.1 Latin America Artificial Implants Sales by Country
3.6.2 Latin America Artificial Implants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Implants Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Implants Sales by Country
3.7.2 Middle East and Africa Artificial Implants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artificial Implants Historic Market Analysis by Type
4.1 Global Artificial Implants Sales Market Share by Type (2016-2021)
4.2 Global Artificial Implants Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Implants Price by Type (2016-2021)
5 Global Artificial Implants Historic Market Analysis by Application
5.1 Global Artificial Implants Sales Market Share by Application (2016-2021)
5.2 Global Artificial Implants Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Implants Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abiomed (USA)
6.1.1 Abiomed (USA) Corporation Information
6.1.2 Abiomed (USA) Description and Business Overview
6.1.3 Abiomed (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abiomed (USA) Product Portfolio
6.1.5 Abiomed (USA) Recent Developments/Updates
6.2 Advanced Bionics Corporation (USA)
6.2.1 Advanced Bionics Corporation (USA) Corporation Information
6.2.2 Advanced Bionics Corporation (USA) Description and Business Overview
6.2.3 Advanced Bionics Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Advanced Bionics Corporation (USA) Product Portfolio
6.2.5 Advanced Bionics Corporation (USA) Recent Developments/Updates
6.3 Bicon(USA)
6.3.1 Bicon(USA) Corporation Information
6.3.2 Bicon(USA) Description and Business Overview
6.3.3 Bicon(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bicon(USA) Product Portfolio
6.3.5 Bicon(USA) Recent Developments/Updates
6.4 Biomet 3i (USA)
6.4.1 Biomet 3i (USA) Corporation Information
6.4.2 Biomet 3i (USA) Description and Business Overview
6.4.3 Biomet 3i (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biomet 3i (USA) Product Portfolio
6.4.5 Biomet 3i (USA) Recent Developments/Updates
6.5 Biotronik(Germany)
6.5.1 Biotronik(Germany) Corporation Information
6.5.2 Biotronik(Germany) Description and Business Overview
6.5.3 Biotronik(Germany) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biotronik(Germany) Product Portfolio
6.5.5 Biotronik(Germany) Recent Developments/Updates
6.6 Boston Scientific Corporation (USA)
6.6.1 Boston Scientific Corporation (USA) Corporation Information
6.6.2 Boston Scientific Corporation (USA) Description and Business Overview
6.6.3 Boston Scientific Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boston Scientific Corporation (USA) Product Portfolio
6.6.5 Boston Scientific Corporation (USA) Recent Developments/Updates
6.7 Cochlear Limited (Australia)
6.6.1 Cochlear Limited (Australia) Corporation Information
6.6.2 Cochlear Limited (Australia) Description and Business Overview
6.6.3 Cochlear Limited (Australia) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cochlear Limited (Australia) Product Portfolio
6.7.5 Cochlear Limited (Australia) Recent Developments/Updates
6.8 Dentsply Sirona (USA)
6.8.1 Dentsply Sirona (USA) Corporation Information
6.8.2 Dentsply Sirona (USA) Description and Business Overview
6.8.3 Dentsply Sirona (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Dentsply Sirona (USA) Product Portfolio
6.8.5 Dentsply Sirona (USA) Recent Developments/Updates
6.9 DePuy Synthes Companies (USA)
6.9.1 DePuy Synthes Companies (USA) Corporation Information
6.9.2 DePuy Synthes Companies (USA) Description and Business Overview
6.9.3 DePuy Synthes Companies (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.9.4 DePuy Synthes Companies (USA) Product Portfolio
6.9.5 DePuy Synthes Companies (USA) Recent Developments/Updates
6.10 Exactech (USA)
6.10.1 Exactech (USA) Corporation Information
6.10.2 Exactech (USA) Description and Business Overview
6.10.3 Exactech (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Exactech (USA) Product Portfolio
6.10.5 Exactech (USA) Recent Developments/Updates
6.11 GS Medical(USA)
6.11.1 GS Medical(USA) Corporation Information
6.11.2 GS Medical(USA) Artificial Implants Description and Business Overview
6.11.3 GS Medical(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GS Medical(USA) Product Portfolio
6.11.5 GS Medical(USA) Recent Developments/Updates
6.12 Institut Straumann AG (Switzerland)
6.12.1 Institut Straumann AG (Switzerland) Corporation Information
6.12.2 Institut Straumann AG (Switzerland) Artificial Implants Description and Business Overview
6.12.3 Institut Straumann AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Institut Straumann AG (Switzerland) Product Portfolio
6.12.5 Institut Straumann AG (Switzerland) Recent Developments/Updates
6.13 Integra Lifesciences Holdings Corporation (USA)
6.13.1 Integra Lifesciences Holdings Corporation (USA) Corporation Information
6.13.2 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Description and Business Overview
6.13.3 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Integra Lifesciences Holdings Corporation (USA) Product Portfolio
6.13.5 Integra Lifesciences Holdings Corporation (USA) Recent Developments/Updates
6.14 Japan Medical Dynamic Marketing (Japan)
6.14.1 Japan Medical Dynamic Marketing (Japan) Corporation Information
6.14.2 Japan Medical Dynamic Marketing (Japan) Artificial Implants Description and Business Overview
6.14.3 Japan Medical Dynamic Marketing (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Japan Medical Dynamic Marketing (Japan) Product Portfolio
6.14.5 Japan Medical Dynamic Marketing (Japan) Recent Developments/Updates
6.15 MED-EL Medical Electronics (Austria)
6.15.1 MED-EL Medical Electronics (Austria) Corporation Information
6.15.2 MED-EL Medical Electronics (Austria) Artificial Implants Description and Business Overview
6.15.3 MED-EL Medical Electronics (Austria) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.15.4 MED-EL Medical Electronics (Austria) Product Portfolio
6.15.5 MED-EL Medical Electronics (Austria) Recent Developments/Updates
6.16 Medtronic plc (Ireland)
6.16.1 Medtronic plc (Ireland) Corporation Information
6.16.2 Medtronic plc (Ireland) Artificial Implants Description and Business Overview
6.16.3 Medtronic plc (Ireland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Medtronic plc (Ireland) Product Portfolio
6.16.5 Medtronic plc (Ireland) Recent Developments/Updates
6.17 Nobel Biocare Services AG (Sweden)
6.17.1 Nobel Biocare Services AG (Sweden) Corporation Information
6.17.2 Nobel Biocare Services AG (Sweden) Artificial Implants Description and Business Overview
6.17.3 Nobel Biocare Services AG (Sweden) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Nobel Biocare Services AG (Sweden) Product Portfolio
6.17.5 Nobel Biocare Services AG (Sweden) Recent Developments/Updates
6.18 RTI Surgical (USA)
6.18.1 RTI Surgical (USA) Corporation Information
6.18.2 RTI Surgical (USA) Artificial Implants Description and Business Overview
6.18.3 RTI Surgical (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.18.4 RTI Surgical (USA) Product Portfolio
6.18.5 RTI Surgical (USA) Recent Developments/Updates
6.19 Showa Ika Kohgyo (Japan)
6.19.1 Showa Ika Kohgyo (Japan) Corporation Information
6.19.2 Showa Ika Kohgyo (Japan) Artificial Implants Description and Business Overview
6.19.3 Showa Ika Kohgyo (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Showa Ika Kohgyo (Japan) Product Portfolio
6.19.5 Showa Ika Kohgyo (Japan) Recent Developments/Updates
6.20 Smith & Nephew Plc (UK)
6.20.1 Smith & Nephew Plc (UK) Corporation Information
6.20.2 Smith & Nephew Plc (UK) Artificial Implants Description and Business Overview
6.20.3 Smith & Nephew Plc (UK) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Smith & Nephew Plc (UK) Product Portfolio
6.20.5 Smith & Nephew Plc (UK) Recent Developments/Updates
6.21 Sonova Holding AG (Switzerland)
6.21.1 Sonova Holding AG (Switzerland) Corporation Information
6.21.2 Sonova Holding AG (Switzerland) Artificial Implants Description and Business Overview
6.21.3 Sonova Holding AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Sonova Holding AG (Switzerland) Product Portfolio
6.21.5 Sonova Holding AG (Switzerland) Recent Developments/Updates
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Artificial Implants Description and Business Overview
6.22.3 Abbott Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Abbott Product Portfolio
6.22.5 Abbott Recent Developments/Updates
6.23 Stryker Corporation (USA)
6.23.1 Stryker Corporation (USA) Corporation Information
6.23.2 Stryker Corporation (USA) Artificial Implants Description and Business Overview
6.23.3 Stryker Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Stryker Corporation (USA) Product Portfolio
6.23.5 Stryker Corporation (USA) Recent Developments/Updates
6.24 Terumo Corporation (Japan)
6.24.1 Terumo Corporation (Japan) Corporation Information
6.24.2 Terumo Corporation (Japan) Artificial Implants Description and Business Overview
6.24.3 Terumo Corporation (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Terumo Corporation (Japan) Product Portfolio
6.24.5 Terumo Corporation (Japan) Recent Developments/Updates
6.25 TTK Healthcare(India)
6.25.1 TTK Healthcare(India) Corporation Information
6.25.2 TTK Healthcare(India) Artificial Implants Description and Business Overview
6.25.3 TTK Healthcare(India) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.25.4 TTK Healthcare(India) Product Portfolio
6.25.5 TTK Healthcare(India) Recent Developments/Updates
6.26 Wright Medical Group(Netherlands)
6.26.1 Wright Medical Group(Netherlands) Corporation Information
6.26.2 Wright Medical Group(Netherlands) Artificial Implants Description and Business Overview
6.26.3 Wright Medical Group(Netherlands) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Wright Medical Group(Netherlands) Product Portfolio
6.26.5 Wright Medical Group(Netherlands) Recent Developments/Updates
6.27 Zimmer Biomet Holdings (USA)
6.27.1 Zimmer Biomet Holdings (USA) Corporation Information
6.27.2 Zimmer Biomet Holdings (USA) Artificial Implants Description and Business Overview
6.27.3 Zimmer Biomet Holdings (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.27.4 Zimmer Biomet Holdings (USA) Product Portfolio
6.27.5 Zimmer Biomet Holdings (USA) Recent Developments/Updates
7 Artificial Implants Manufacturing Cost Analysis
7.1 Artificial Implants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Implants
7.4 Artificial Implants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Implants Distributors List
8.3 Artificial Implants Customers
9 Artificial Implants Market Dynamics
9.1 Artificial Implants Industry Trends
9.2 Artificial Implants Growth Drivers
9.3 Artificial Implants Market Challenges
9.4 Artificial Implants Market Restraints
10 Global Market Forecast
10.1 Artificial Implants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Implants by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Artificial Implants by Type (2022-2030)
10.2 Artificial Implants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Implants by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Artificial Implants by Application (2022-2030)
10.3 Artificial Implants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Implants by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Artificial Implants by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Artificial Implants
1.2 Artificial Implants Segment by Type
1.2.1 Global Artificial Implants Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Orthopedic Implants
1.2.3 Dental Implants
1.2.4 Cardiac Implants
1.2.5 Cochlear Implants
1.3 Artificial Implants Segment by Application
1.3.1 Artificial Implants Sales Comparison by Application: (2022-2030)
1.3.2 Hospitals
1.3.3 Clinical Research Institutions
1.3.4 Others
1.4 Global Artificial Implants Market Size Estimates and Forecasts
1.4.1 Global Artificial Implants Revenue 2016-2030
1.4.2 Global Artificial Implants Sales 2016-2030
1.4.3 Artificial Implants Market Size by Region: 2016 Versus 2022 Versus 2030
2 Artificial Implants Market Competition by Manufacturers
2.1 Global Artificial Implants Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Implants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Implants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Implants Manufacturing Sites, Area Served, Product Type
2.5 Artificial Implants Market Competitive Situation and Trends
2.5.1 Artificial Implants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Implants Players Market Share by Revenue
2.5.3 Global Artificial Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Implants Retrospective Market Scenario by Region
3.1 Global Artificial Implants Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Artificial Implants Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Artificial Implants Market Facts & Figures by Country
3.3.1 North America Artificial Implants Sales by Country
3.3.2 North America Artificial Implants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Implants Market Facts & Figures by Country
3.4.1 Europe Artificial Implants Sales by Country
3.4.2 Europe Artificial Implants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Implants Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Implants Sales by Region
3.5.2 Asia Pacific Artificial Implants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Implants Market Facts & Figures by Country
3.6.1 Latin America Artificial Implants Sales by Country
3.6.2 Latin America Artificial Implants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Implants Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Implants Sales by Country
3.7.2 Middle East and Africa Artificial Implants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artificial Implants Historic Market Analysis by Type
4.1 Global Artificial Implants Sales Market Share by Type (2016-2021)
4.2 Global Artificial Implants Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Implants Price by Type (2016-2021)
5 Global Artificial Implants Historic Market Analysis by Application
5.1 Global Artificial Implants Sales Market Share by Application (2016-2021)
5.2 Global Artificial Implants Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Implants Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abiomed (USA)
6.1.1 Abiomed (USA) Corporation Information
6.1.2 Abiomed (USA) Description and Business Overview
6.1.3 Abiomed (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abiomed (USA) Product Portfolio
6.1.5 Abiomed (USA) Recent Developments/Updates
6.2 Advanced Bionics Corporation (USA)
6.2.1 Advanced Bionics Corporation (USA) Corporation Information
6.2.2 Advanced Bionics Corporation (USA) Description and Business Overview
6.2.3 Advanced Bionics Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Advanced Bionics Corporation (USA) Product Portfolio
6.2.5 Advanced Bionics Corporation (USA) Recent Developments/Updates
6.3 Bicon(USA)
6.3.1 Bicon(USA) Corporation Information
6.3.2 Bicon(USA) Description and Business Overview
6.3.3 Bicon(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bicon(USA) Product Portfolio
6.3.5 Bicon(USA) Recent Developments/Updates
6.4 Biomet 3i (USA)
6.4.1 Biomet 3i (USA) Corporation Information
6.4.2 Biomet 3i (USA) Description and Business Overview
6.4.3 Biomet 3i (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biomet 3i (USA) Product Portfolio
6.4.5 Biomet 3i (USA) Recent Developments/Updates
6.5 Biotronik(Germany)
6.5.1 Biotronik(Germany) Corporation Information
6.5.2 Biotronik(Germany) Description and Business Overview
6.5.3 Biotronik(Germany) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biotronik(Germany) Product Portfolio
6.5.5 Biotronik(Germany) Recent Developments/Updates
6.6 Boston Scientific Corporation (USA)
6.6.1 Boston Scientific Corporation (USA) Corporation Information
6.6.2 Boston Scientific Corporation (USA) Description and Business Overview
6.6.3 Boston Scientific Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boston Scientific Corporation (USA) Product Portfolio
6.6.5 Boston Scientific Corporation (USA) Recent Developments/Updates
6.7 Cochlear Limited (Australia)
6.6.1 Cochlear Limited (Australia) Corporation Information
6.6.2 Cochlear Limited (Australia) Description and Business Overview
6.6.3 Cochlear Limited (Australia) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cochlear Limited (Australia) Product Portfolio
6.7.5 Cochlear Limited (Australia) Recent Developments/Updates
6.8 Dentsply Sirona (USA)
6.8.1 Dentsply Sirona (USA) Corporation Information
6.8.2 Dentsply Sirona (USA) Description and Business Overview
6.8.3 Dentsply Sirona (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Dentsply Sirona (USA) Product Portfolio
6.8.5 Dentsply Sirona (USA) Recent Developments/Updates
6.9 DePuy Synthes Companies (USA)
6.9.1 DePuy Synthes Companies (USA) Corporation Information
6.9.2 DePuy Synthes Companies (USA) Description and Business Overview
6.9.3 DePuy Synthes Companies (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.9.4 DePuy Synthes Companies (USA) Product Portfolio
6.9.5 DePuy Synthes Companies (USA) Recent Developments/Updates
6.10 Exactech (USA)
6.10.1 Exactech (USA) Corporation Information
6.10.2 Exactech (USA) Description and Business Overview
6.10.3 Exactech (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Exactech (USA) Product Portfolio
6.10.5 Exactech (USA) Recent Developments/Updates
6.11 GS Medical(USA)
6.11.1 GS Medical(USA) Corporation Information
6.11.2 GS Medical(USA) Artificial Implants Description and Business Overview
6.11.3 GS Medical(USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GS Medical(USA) Product Portfolio
6.11.5 GS Medical(USA) Recent Developments/Updates
6.12 Institut Straumann AG (Switzerland)
6.12.1 Institut Straumann AG (Switzerland) Corporation Information
6.12.2 Institut Straumann AG (Switzerland) Artificial Implants Description and Business Overview
6.12.3 Institut Straumann AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Institut Straumann AG (Switzerland) Product Portfolio
6.12.5 Institut Straumann AG (Switzerland) Recent Developments/Updates
6.13 Integra Lifesciences Holdings Corporation (USA)
6.13.1 Integra Lifesciences Holdings Corporation (USA) Corporation Information
6.13.2 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Description and Business Overview
6.13.3 Integra Lifesciences Holdings Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Integra Lifesciences Holdings Corporation (USA) Product Portfolio
6.13.5 Integra Lifesciences Holdings Corporation (USA) Recent Developments/Updates
6.14 Japan Medical Dynamic Marketing (Japan)
6.14.1 Japan Medical Dynamic Marketing (Japan) Corporation Information
6.14.2 Japan Medical Dynamic Marketing (Japan) Artificial Implants Description and Business Overview
6.14.3 Japan Medical Dynamic Marketing (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Japan Medical Dynamic Marketing (Japan) Product Portfolio
6.14.5 Japan Medical Dynamic Marketing (Japan) Recent Developments/Updates
6.15 MED-EL Medical Electronics (Austria)
6.15.1 MED-EL Medical Electronics (Austria) Corporation Information
6.15.2 MED-EL Medical Electronics (Austria) Artificial Implants Description and Business Overview
6.15.3 MED-EL Medical Electronics (Austria) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.15.4 MED-EL Medical Electronics (Austria) Product Portfolio
6.15.5 MED-EL Medical Electronics (Austria) Recent Developments/Updates
6.16 Medtronic plc (Ireland)
6.16.1 Medtronic plc (Ireland) Corporation Information
6.16.2 Medtronic plc (Ireland) Artificial Implants Description and Business Overview
6.16.3 Medtronic plc (Ireland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Medtronic plc (Ireland) Product Portfolio
6.16.5 Medtronic plc (Ireland) Recent Developments/Updates
6.17 Nobel Biocare Services AG (Sweden)
6.17.1 Nobel Biocare Services AG (Sweden) Corporation Information
6.17.2 Nobel Biocare Services AG (Sweden) Artificial Implants Description and Business Overview
6.17.3 Nobel Biocare Services AG (Sweden) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Nobel Biocare Services AG (Sweden) Product Portfolio
6.17.5 Nobel Biocare Services AG (Sweden) Recent Developments/Updates
6.18 RTI Surgical (USA)
6.18.1 RTI Surgical (USA) Corporation Information
6.18.2 RTI Surgical (USA) Artificial Implants Description and Business Overview
6.18.3 RTI Surgical (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.18.4 RTI Surgical (USA) Product Portfolio
6.18.5 RTI Surgical (USA) Recent Developments/Updates
6.19 Showa Ika Kohgyo (Japan)
6.19.1 Showa Ika Kohgyo (Japan) Corporation Information
6.19.2 Showa Ika Kohgyo (Japan) Artificial Implants Description and Business Overview
6.19.3 Showa Ika Kohgyo (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Showa Ika Kohgyo (Japan) Product Portfolio
6.19.5 Showa Ika Kohgyo (Japan) Recent Developments/Updates
6.20 Smith & Nephew Plc (UK)
6.20.1 Smith & Nephew Plc (UK) Corporation Information
6.20.2 Smith & Nephew Plc (UK) Artificial Implants Description and Business Overview
6.20.3 Smith & Nephew Plc (UK) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Smith & Nephew Plc (UK) Product Portfolio
6.20.5 Smith & Nephew Plc (UK) Recent Developments/Updates
6.21 Sonova Holding AG (Switzerland)
6.21.1 Sonova Holding AG (Switzerland) Corporation Information
6.21.2 Sonova Holding AG (Switzerland) Artificial Implants Description and Business Overview
6.21.3 Sonova Holding AG (Switzerland) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Sonova Holding AG (Switzerland) Product Portfolio
6.21.5 Sonova Holding AG (Switzerland) Recent Developments/Updates
6.22 Abbott
6.22.1 Abbott Corporation Information
6.22.2 Abbott Artificial Implants Description and Business Overview
6.22.3 Abbott Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Abbott Product Portfolio
6.22.5 Abbott Recent Developments/Updates
6.23 Stryker Corporation (USA)
6.23.1 Stryker Corporation (USA) Corporation Information
6.23.2 Stryker Corporation (USA) Artificial Implants Description and Business Overview
6.23.3 Stryker Corporation (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Stryker Corporation (USA) Product Portfolio
6.23.5 Stryker Corporation (USA) Recent Developments/Updates
6.24 Terumo Corporation (Japan)
6.24.1 Terumo Corporation (Japan) Corporation Information
6.24.2 Terumo Corporation (Japan) Artificial Implants Description and Business Overview
6.24.3 Terumo Corporation (Japan) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Terumo Corporation (Japan) Product Portfolio
6.24.5 Terumo Corporation (Japan) Recent Developments/Updates
6.25 TTK Healthcare(India)
6.25.1 TTK Healthcare(India) Corporation Information
6.25.2 TTK Healthcare(India) Artificial Implants Description and Business Overview
6.25.3 TTK Healthcare(India) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.25.4 TTK Healthcare(India) Product Portfolio
6.25.5 TTK Healthcare(India) Recent Developments/Updates
6.26 Wright Medical Group(Netherlands)
6.26.1 Wright Medical Group(Netherlands) Corporation Information
6.26.2 Wright Medical Group(Netherlands) Artificial Implants Description and Business Overview
6.26.3 Wright Medical Group(Netherlands) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Wright Medical Group(Netherlands) Product Portfolio
6.26.5 Wright Medical Group(Netherlands) Recent Developments/Updates
6.27 Zimmer Biomet Holdings (USA)
6.27.1 Zimmer Biomet Holdings (USA) Corporation Information
6.27.2 Zimmer Biomet Holdings (USA) Artificial Implants Description and Business Overview
6.27.3 Zimmer Biomet Holdings (USA) Artificial Implants Sales, Revenue and Gross Margin (2016-2021)
6.27.4 Zimmer Biomet Holdings (USA) Product Portfolio
6.27.5 Zimmer Biomet Holdings (USA) Recent Developments/Updates
7 Artificial Implants Manufacturing Cost Analysis
7.1 Artificial Implants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Implants
7.4 Artificial Implants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Implants Distributors List
8.3 Artificial Implants Customers
9 Artificial Implants Market Dynamics
9.1 Artificial Implants Industry Trends
9.2 Artificial Implants Growth Drivers
9.3 Artificial Implants Market Challenges
9.4 Artificial Implants Market Restraints
10 Global Market Forecast
10.1 Artificial Implants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Implants by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Artificial Implants by Type (2022-2030)
10.2 Artificial Implants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Implants by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Artificial Implants by Application (2022-2030)
10.3 Artificial Implants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Implants by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Artificial Implants by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI